Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis.

PubWeight™: 1.77‹?› | Rank: Top 3%

🔗 View Article (PMC 264620)

Published in Infect Immun on September 01, 1983

Authors

D G Burstyn, L J Baraff, M S Peppler, R D Leake, J St Geme, C R Manclark

Articles citing this

The efficacy of DPT and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age. Bull World Health Organ (1985) 2.35

Filamentous hemagglutinin has a major role in mediating adherence of Bordetella pertussis to human WiDr cells. Infect Immun (1986) 2.18

Sensitivity and specificity of clinical case definitions for pertussis. Am J Public Health (1988) 1.93

Laboratory diagnosis of pertussis: state of the art in 1997. J Clin Microbiol (1997) 1.84

Neonatal administration of idiotype or antiidiotype primes for protection against Escherichia coli K13 infection in mice. J Exp Med (1984) 1.73

Evaluation of culture, immunofluorescence, and serology for the diagnosis of pertussis. J Clin Microbiol (1989) 1.64

Maternal vaccination: moving the science forward. Hum Reprod Update (2014) 1.50

Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine. Infect Immun (1996) 1.33

Evaluation of serologic assays for diagnosis of whooping cough. J Clin Microbiol (1988) 1.32

Efficacy of enzyme-linked immunosorbent assay for rapid diagnosis of Bordetella pertussis infection. J Clin Microbiol (1987) 1.29

Pertussis: the disease and new diagnostic methods. Clin Microbiol Rev (1988) 1.16

Engineering of genetically detoxified pertussis toxin analogs for development of a recombinant whooping cough vaccine. Infect Immun (1990) 1.08

The past, present, and future of pertussis. The role of adults in epidemiology and future control. West J Med (1989) 1.07

Pertussis: epidemiology and control. Bull World Health Organ (1986) 1.06

Immunoblot analysis of humoral immune responses following infection with Bordetella pertussis or immunization with diphtheria-tetanus-pertussis vaccine. J Clin Microbiol (1988) 1.02

An immunogenic and protective alphavirus replicon particle-based dengue vaccine overcomes maternal antibody interference in weanling mice. J Virol (2007) 0.95

Targeting regulatory T cells to improve vaccine immunogenicity in early life. Front Microbiol (2014) 0.88

Antibodies to Bordetella pertussis in human colostrum and their protective activity against aerosol infection of mice. Infect Immun (1985) 0.87

New, practical approach to detecting antibody to pertussis toxin for public health and clinical laboratories. J Clin Microbiol (1988) 0.85

Maternal immunity and antibody response of neonatal mice to pneumococcal type 19F polysaccharide. J Clin Microbiol (1991) 0.83

Immune suppression and induction of gamma interferon by pertussis toxin. Infect Immun (1985) 0.82

Development of a rapid diagnostic test for pertussis: direct detection of pertussis toxin in respiratory secretions. J Clin Microbiol (1989) 0.82

Laboratory Diagnosis of Pertussis. Clin Microbiol Rev (2015) 0.81

Simple, efficient purification of filamentous hemagglutinin and pertussis toxin from Bordetella pertussis by hydrophobic and affinity interaction. J Clin Microbiol (1990) 0.79

Preparation of filamentous hemagglutinin from Bordetella pertussis and assay for serum antibodies to filamentous hemagglutinin and pertussis toxin for clinical and public health laboratories. J Clin Microbiol (1989) 0.78

Articles cited by this

Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. J Immunol (1972) 40.51

Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics (1981) 7.58

Mouse-protecting and histamine-sensitizing activities of pertussigen and fimbrial hemagglutinin from Bordetella pertussis. Infect Immun (1981) 2.94

Separation and purification of the hemagglutinins from Bordetella pertussis. Infect Immun (1983) 2.85

Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis. Infect Immun (1981) 2.77

Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure. J Pediatr (1977) 2.66

Studies of the immunology of the newborn infant. II. Interference with active immunization by passive transplacental circulating antibody. Pediatrics (1952) 2.53

Serologic diagnosis of whooping cough by an enzyme-linked immunosorbent assay using fimbrial hemagglutinin as antigen. J Infect Dis (1982) 1.80

Diphtheria-pertussis-tetanus vaccine: reactogenicity of commercial products. Pediatrics (1979) 1.65

Living attenuated measles-virus vaccine in early infancy. Studies of the role of passive antibody in immunization. N Engl J Med (1961) 1.60

Serological diagnosis of pertussis: IgM, IgA and IgG antibodies against Bordetella pertussis measured by enzyme-linked immunosorbent assay (ELISA). Scand J Infect Dis (1982) 1.56

Agglutinin response to pertussis vaccination in the child. Br Med J (1971) 1.51

Detection of Bordetella pertussis antibodies in human sera by complement-fixation and immunofluorescence. J Hyg (Lond) (1972) 1.33

The serological diagnosis of whooping cough. J Hyg (Lond) (1979) 1.31

Detection of antibodies in human serum against the fimbrial haemagglutinin of Bordetella pertussis by enzyme-linked immunosorbent assay. J Med Microbiol (1982) 1.30

Immunization and antibody response in the newborn infant. I. Pertussis inoculation within twenty-four hours of birth. N Engl J Med (1965) 1.28

Pertussis antibodies in the sera of children exposed to Bordetella pertussis by vaccination or infection. J Hyg (Lond) (1973) 1.16

Agglutinin response to pertussis vaccine. I. Effect of dosage and interval. J Pediatr (1971) 1.15

Enzyme-linked immunosorbent assay for detection of pertussis immunoglobulin A in nasopharyngeal secretions as an indicator of recent infection. J Clin Microbiol (1981) 1.13

immunoglobulin and histamine-sensitivity response of mice to live Bordetella pertussis. Infect Immun (1973) 1.08

Respiratory and humoral immune response to aerosol and intramuscular pertussis vaccine. J Hyg (Lond) (1975) 1.08

Development of antibodies in children convalescent from whooping cough. Proc Soc Exp Biol Med (1954) 1.00

Pertussis vaccine research. Bull World Health Organ (1981) 0.99

RESPONSES OF INFANTS TO DTP-P VACCINE USED IN NINE INJECTION SCHEDULES. Public Health Rep (1964) 0.97

DTP and DTP-inactivated polio vaccines: comparison of adverse reactions and IGG, IGM and IGA antibody responses to DTP. Acta Paediatr Scand (1980) 0.96

The vaccination of the newborn infant against pertussis. J Pediatr (1958) 0.92

Neonatal response to DTP vaccines. Public Health Rep (1958) 0.87

The IgM and IgG response to Bordetella pertussis vaccination and infection. J Med Microbiol (1981) 0.85

Studies on the prophylaxis and treatment of tetanus. II. Studies pertaining to treatment. Bull Johns Hopkins Hosp (1958) 0.84

Bactericidal antibody in serum during infection with Bordetalla pertussis. J Infect Dis (1973) 0.80

Articles by these authors

Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics (1981) 7.58

Genetic diversity and relationships in populations of Bordetella spp. J Bacteriol (1986) 4.48

Use of pulsed-field gel electrophoresis for epidemiological study of Bordetella pertussis in a whooping cough outbreak. J Clin Microbiol (1994) 4.13

Extracytoplasmic adenylate cyclase of Bordetella pertussis. Proc Natl Acad Sci U S A (1976) 3.57

Pertussis toxin. Affinity purification of a new ADP-ribosyltransferase. J Biol Chem (1983) 3.31

Invasion of HeLa 229 cells by virulent Bordetella pertussis. Infect Immun (1989) 3.27

Separation and purification of the hemagglutinins from Bordetella pertussis. Infect Immun (1983) 2.85

Implementation of clinical guidelines using a computer charting system. Effect on the initial care of health care workers exposed to body fluids. JAMA (1997) 2.83

Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis. Infect Immun (1981) 2.77

Identification of a 69-kilodalton nonfimbrial protein as an agglutinogen of Bordetella pertussis. Infect Immun (1988) 2.55

Isolation and characterization of isogenic pairs of domed hemolytic and flat nonhemolytic colony types of Bordetella pertussis. Infect Immun (1982) 2.47

ADP-ribosylation of transducin by pertussis toxin blocks the light-stimulated hydrolysis of GTP and cGMP in retinal photoreceptors. J Biol Chem (1984) 2.39

Haemophilus influenzae meningitis. A national study of secondary spread in household contacts. N Engl J Med (1979) 2.34

Aerosol infection of mice with Bordetella pertussis. Infect Immun (1980) 2.31

Two physically and serologically distinct lipopolysaccharide profiles in strains of Bordetella pertussis and their phenotype variants. Infect Immun (1984) 2.30

Phase-shift markers in Bordetella: alterations in envelope proteins. J Infect Dis (1981) 2.23

Bacterial meningitis and septicemia in sickle cell disease. Am J Dis Child (1977) 2.19

Filamentous hemagglutinin has a major role in mediating adherence of Bordetella pertussis to human WiDr cells. Infect Immun (1986) 2.18

DTP-associated reactions: an analysis by injection site, manufacturer, prior reactions, and dose. Pediatrics (1984) 2.15

Pulse oximetry as a fifth pediatric vital sign. Pediatrics (1997) 2.11

Adherence of isolates of Neisseria meningitidis from patients and carriers to human buccal epithelial cells. J Infect Dis (1980) 2.05

Measurement of "true" glucose production rates in infancy and childhood with 6,6-dideuteroglucose. Diabetes (1977) 2.02

Protection against group B Neisseria meningitidis disease: preparation of soluble protein and protein-polysaccharide immunogens. Infect Immun (1982) 1.96

Protective activities of the filamentous hemagglutinin and the lymphocytosis-promoting factor of Bordetella pertussis in mice. J Infect Dis (1984) 1.96

Sensitivity and specificity of clinical case definitions for pertussis. Am J Public Health (1988) 1.93

Comparison of type 2 and type 6 fimbriae of Bordetella pertussis by using agglutinating monoclonal antibodies. Infect Immun (1988) 1.92

Efficacy of cervical spine immobilization methods. J Trauma (1983) 1.89

Lectin-like binding of pertussis toxin to a 165-kilodalton Chinese hamster ovary cell glycoprotein. J Biol Chem (1988) 1.88

Comparative roles of the Arg-Gly-Asp sequence present in the Bordetella pertussis adhesins pertactin and filamentous hemagglutinin. Infect Immun (1992) 1.85

Surface colonization with coagulase-negative staphylococci in premature neonates. J Pediatr (1989) 1.84

Intracellular localization of the dermonecrotic toxin of Bordetella pertussis. Infect Immun (1979) 1.83

Bordetella parapertussis invasion of HeLa 229 cells and human respiratory epithelial cells in primary culture. Infect Immun (1989) 1.78

Agglutinating monoclonal antibodies that specifically recognize lipooligosaccharide A of Bordetella pertussis. Infect Immun (1988) 1.71

Immunologic response to early and routine DTP immunization in infants. Pediatrics (1984) 1.71

Binding of pertussis toxin to eucaryotic cells and glycoproteins. Infect Immun (1989) 1.71

Pertussis toxin substrate, the putative Ni component of adenylyl cyclases, is an alpha beta heterodimer regulated by guanine nucleotide and magnesium. Proc Natl Acad Sci U S A (1983) 1.67

Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis. J Exp Med (1990) 1.67

Infants and children with convulsions and hypotonic-hyporesponsive episodes following diphtheria-tetanus-pertussis immunization: follow-up evaluation. Pediatrics (1988) 1.66

Ns and Ni, the stimulatory and inhibitory regulatory components of adenylyl cyclases. Purification of the human erythrocyte proteins without the use of activating regulatory ligands. J Biol Chem (1984) 1.62

Stimulation and inhibition of adenylyl cyclases mediated by distinct regulatory proteins. Nature (1983) 1.59

Admission decisions in emergency department chest pain patients at low risk for myocardial infarction: patient versus physician preferences. Ann Emerg Med (1996) 1.58

Nonfermentative bacilli associated with man. I. Nomenclature. Am J Clin Pathol (1970) 1.57

Role of the A subunit of pertussis toxin in alteration of Chinese hamster ovary cell morphology. Infect Immun (1987) 1.52

A comparison of pulse oximetry and respiratory rate in patient screening. Respir Med (1996) 1.51

Identification of Bordetella pertussis infection by shared-primer PCR. J Clin Microbiol (1994) 1.49

Purification and characterization of fimbriae isolated from Bordetella pertussis. Infect Immun (1985) 1.47

Incorporating patient preferences into practice guidelines: management of children with fever without source. Ann Emerg Med (1994) 1.44

Monoclonal antibodies to pertussis toxin: utilization as probes of toxin function. Hybridoma (1989) 1.43

The role of antibiotics, immunizations, and adenoviruses in pertussis. Pediatrics (1978) 1.42

Capillary refill--is it a useful predictor of hypovolemic states? Ann Emerg Med (1991) 1.41

Major outbreak of pertussis in northern Alberta, Canada: analysis of discrepant direct fluorescent-antibody and culture results by using polymerase chain reaction methodology. J Clin Microbiol (1993) 1.39

Vasopressin levels in infants during the course of aseptic and bacterial meningitis. Am J Dis Child (1991) 1.39

Care of the febrile child: an annotated bibliography. Am J Emerg Med (1991) 1.38

A comparison of laboratory and clinical methods for diagnosing pertussis in an outbreak in a facility for the developmentally disabled. J Infect Dis (1988) 1.37

Phenotypic variation and modulation in Bordetella bronchiseptica. Infect Immun (1984) 1.36

Structural characterization of pertussis toxin A subunit. J Biol Chem (1987) 1.36

Immune response to the B oligomer of pertussis toxin. Infect Immun (1987) 1.36

Epitopes on the S1 subunit of pertussis toxin recognized by monoclonal antibodies. Infect Immun (1989) 1.32

The significance of anaerobes in neonatal bacteremia: analysis of 23 cases and review of the literature. Pediatrics (1974) 1.28

Pertussis encephalopathy with a normal brain biopsy and elevated lymphocytosis-promoting factor antibodies. Pediatr Infect Dis (1984) 1.25

Pertussis toxin inhibition of chemotaxis and the ADP-ribosylation of a membrane protein in a human-mouse hybrid cell line. Proc Natl Acad Sci U S A (1985) 1.24

Possible temporal association between diphtheria-tetanus toxoid-pertussis vaccination and sudden infant death syndrome. Pediatr Infect Dis (1983) 1.23

Failure of cefamandole in treatment of meningitis due to Haemophilus influenzae type b. J Infect Dis (1978) 1.22

Advance directives. Effect of type of directive on physicians' therapeutic decisions. Arch Intern Med (1993) 1.22

Effect of emergency department information on patient satisfaction. Ann Emerg Med (1993) 1.19

Hyperviscosity syndrome associated with necrotizing enterocolitis. Am J Dis Child (1975) 1.19

Protection against group B Neisseria meningitidis disease: effect of serogroup B polysaccharide and polymyxin B on immunogenicity of serotype protein preparations. Infect Immun (1982) 1.18

The radiologic localization of the major aortic tributaries in the newborn infant. J Pediatr (1972) 1.18

Adenine nucleotides promote dissociation of pertussis toxin subunits. J Biol Chem (1986) 1.17

Maintenance of biological activity of pertussis toxin radioiodinated while bound to fetuin-agarose. Infect Immun (1987) 1.14

Cloning and sequencing of the structural gene for the porin protein of Bordetella pertussis. Mol Microbiol (1991) 1.13

In vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factor. Infect Immun (1984) 1.12

Human rabies. West J Med (1978) 1.12

Biphasic effect of pertussis vaccine on serum insulin in mice. Infect Immun (1983) 1.11

Implementation of clinical guidelines via a computer charting system: effect on the care of febrile children less than three years of age. J Am Med Inform Assoc (2000) 1.11

Use of glycosyltransferases to restore pertussis toxin receptor activity to asialoagalactofetuin. J Biol Chem (1988) 1.10

Stimulation of the thiol-dependent ADP-ribosyltransferase and NAD glycohydrolase activities of Bordetella pertussis toxin by adenine nucleotides, phospholipids, and detergents. Biochemistry (1986) 1.10

Phase-shift markers in the genus Bordetella: loss of cytochrome d-629 in phase IV variants. Microbios (1981) 1.10

Purification and characterization of serotype 6 fimbriae from Bordetella pertussis and comparison of their properties with serotype 2 fimbriae. Infect Immun (1987) 1.10

Povidone-iodine for ophthalmia neonatorum prophylaxis. Am J Ophthalmol (1994) 1.10

Exposure of emergency medicine personnel to ionizing radiation during cervical spine radiography. Ann Emerg Med (1989) 1.09

Mechanism of pertussis toxin B oligomer-mediated protection against Bordetella pertussis respiratory infection. Infect Immun (1990) 1.08

Inulin clearance in the newborn infant: relationship to gestational and postnatal age. Pediatr Res (1976) 1.08

Penetration of cefamandole into spinal fluid. Antimicrob Agents Chemother (1977) 1.08

Biochemical characterization of an invariant polypeptide associated with Ia antigens in human and mouse. Mol Immunol (1983) 1.08

Lymphocytosis-promoting factor of Bordetella pertussis alters mononuclear phagocyte circulation and response to inflammation. Infect Immun (1984) 1.07

The past, present, and future of pertussis. The role of adults in epidemiology and future control. West J Med (1989) 1.07

Regulation of Bordetella pertussis extracytoplasmic adenylate cyclase. Adv Cyclic Nucleotide Res (1978) 1.06

Immunological characterization of the lipooligosaccharide B band of Bordetella pertussis. Infect Immun (1992) 1.05

Effect of routine emergency department triage pulse oximetry screening on medical management. Chest (1995) 1.05